Eledon Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead pro…

Biotechnology
US, Irvine [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ELDN's Analysis
CIK: 1404281 CUSIP: 28617K101 ISIN: US28617K1016 LEI: - UEI: -
Secondary Listings
ELDN has no secondary listings inside our databases.